| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 04/14/2005 | WO2005005424B1 Aztreonam l-lysine and methods for the preparation thereof |
| 04/14/2005 | WO2004110374A3 3,4-disubstituted benzamidines and benzylamines, and analogues thereof, useful as serine protease inhibitors |
| 04/14/2005 | WO2004110342A3 Novel polymorph of gabapentin and its conversion to gabapentin form-ii |
| 04/14/2005 | US20050080262 Process for producing quinazolin-4-one derivative |
| 04/14/2005 | US20050080178 Making a synthetic hydrotalcite using an organic carboxylate containing a heteroatom selected from nitrogen, phosphorous, sulfur and halogen, for example an amino acid; amino acid of hydrotalcite bonds with maleated polyolefin for use in blends, polymer nanocomposites |
| 04/14/2005 | US20050080177 Novel hydrotalcites, syntheses, and uses |
| 04/14/2005 | US20050079587 Beginning with diastereo-and enantioselective reduction of a keto ester to obtain the hydroxy ester; use in drug preparation |
| 04/14/2005 | US20050079529 Using laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics |
| 04/14/2005 | US20050079209 Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 04/14/2005 | DE19919490B4 Verfahren zur Abtrennung organischer Substanzen aus einem wässrigen Gemisch A method for separating organic substances from an aqueous mixture |
| 04/13/2005 | EP1521735A2 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 04/13/2005 | EP1031555B1 Difluoromethoxybenzene derivatives and their use as intermediates |
| 04/13/2005 | CN1606606A Water-base composition and crosslinking agent for water-soluble polymers |
| 04/13/2005 | CN1196672C Non-hydroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same |
| 04/13/2005 | CN1196671C Mono-and-disubstituted 2-pyrolyl gamma-aminobutric acids |
| 04/12/2005 | US6878828 Coupling cysteine with benzonitrile, then esterifying, alkylating, hydrolyzing and reacting with acids to form 2-methylcysteine |
| 04/12/2005 | US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough |
| 04/12/2005 | US6878723 Carbocyclic and/or heterocyclic amino carboxylic acids, e.g., 2-aminomethyl-6-(p-benzylphenoxy)hexanoic acid; leukotriene A4 hydrolase; treating arthritis and psoriasis; hematoprotective and antimitotic agents |
| 04/12/2005 | US6878718 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/07/2005 | WO2005030701A2 Process for the preparation of lower toxicity quaternary ammonium compounds and compositions thereof |
| 04/07/2005 | WO2005030700A2 Amino acids with affinity for the alpha2delta-protein |
| 04/07/2005 | WO2005030135A2 Nitrosated glutamic acid compounds, compositions and methods of use |
| 04/07/2005 | WO2004110364A9 Thiotungstate analogues and uses thereof |
| 04/07/2005 | WO2004093806A3 Compounds for the treatment of metabolic disorders |
| 04/07/2005 | US20050075477 Bis-2-hydroxydiethylamine and maleic ester end capped polyamine; rapid hard drying dual component coatings; polyurethane prepolymers |
| 04/07/2005 | US20050075377 Compounds for elevating plasma lipid levels with prodrugs for humans and other mammals |
| 04/07/2005 | CA2540208A1 Amino acids with affinity for the alpha2delta-protein |
| 04/07/2005 | CA2539973A1 Nitrosated glutamic acid compounds, compositions and methods of use |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | CN1604889A Method for producing 2-halogenacyl-3-amino-acrylic acid derivatives |
| 04/06/2005 | CN1604818A Catalysts for producing carboxylic acid salts |
| 04/06/2005 | CN1603304A Substituted amide herbicides |
| 04/06/2005 | CN1195759C Process for preparation of benzoxazine derivatives and intermediates therefor |
| 04/06/2005 | CN1195736C Gatrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 04/06/2005 | CN1195733C Method for preparation of aryl alkyl hydrogen peroxide |
| 04/06/2005 | CN1195732C Substituted sulfonyl aminomethyl benzoic acid (derivatives) and method for production thereof |
| 04/05/2005 | US6875890 Reacting chloroacetic acid with dimethylamine; salt forming using hydrogen chloride |
| 04/05/2005 | US6875883 Forming a phenyl-thiazoles chemical intermediates for making antioxidants, ferrielectric liquid crystal dopant, picornaviral viricides, antiinflammatory agents, anti-asthma agents, and fibringoen antagonists |
| 04/05/2005 | US6875882 Ferroelectric liquid crystals, antihistamines, antiinflammatory agents, viricides |
| 04/05/2005 | US6875874 Using thionyl chloride |
| 04/05/2005 | CA1341478C Therapeutic methods using catalytic antibodies |
| 03/31/2005 | WO2005028471A1 Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors |
| 03/31/2005 | WO2005028432A1 Hyperbranched (pamam) polymers via a one pot process |
| 03/31/2005 | WO2005028419A2 Asymmetric reductive amination of keto acid derivatives for producing amino acid derivatives |
| 03/31/2005 | US20050070715 Methods for synthesis of acyloxyalkyl compounds |
| 03/31/2005 | US20050069515 Process and composition for lower toxicity quaternary ammonium compounds |
| 03/31/2005 | CA2538591A1 Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors |
| 03/30/2005 | EP1517879A1 Aminoalkylphenols, methods of using and making the same |
| 03/30/2005 | EP1235788B1 Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties |
| 03/30/2005 | CN1602294A Acetyl l-carnitine salt with a dicarboxilic organic acid and process for preparing same |
| 03/30/2005 | CN1602290A Process for the synthesis of chirally pure beta -amino-alcohols |
| 03/30/2005 | CN1602184A Compounds for a controlled release of active molecules |
| 03/30/2005 | CN1194960C Method for preparing 4,5-diamino shikimic acid derivative |
| 03/29/2005 | US6872856 Cyclic ketones, their preparation and their use in the synthesis of amino acids |
| 03/29/2005 | US6872823 Bactericides; chemical intermediates |
| 03/29/2005 | US6872699 Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 protein |
| 03/29/2005 | CA2125717C Compounds containing tertiary amino groups, a process for their production and their use as catalysts |
| 03/24/2005 | WO2005026106A1 Process of hydrocyanation of unsaturated carboxylic acid derivatives |
| 03/24/2005 | WO2005025555A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 03/24/2005 | US20050065367 Method for producing optically active beta-phenylalanine |
| 03/24/2005 | US20050065366 Method for producing optically active beta-phenylalanine compounds |
| 03/24/2005 | CA2788502A1 Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide |
| 03/23/2005 | CN1599719A Crystals of non-natural-type stereoisomer salt of monatin and use thereof |
| 03/23/2005 | CN1597661A Glutamic acid extraction technology in production of glutamic acid by fermentation method |
| 03/22/2005 | US6870065 Such as N-hydroxysuccinimidyl-5-(N,N-bis-(2-(4-(N-((3-hydroxy-4-(methoxy-carbonyl) phenyl)methyl)carbamoyl) butanoylamino)ethyl)carbamoyl)butanoate for biochemical conjugation |
| 03/22/2005 | US6870026 Biodegradable chelate compounds formed by one pot amidation of anhydrides with ethanolamine, used for agricultural applications such as fertilizers |
| 03/22/2005 | US6869974 Pharmaceutical compounds |
| 03/22/2005 | CA2257772C Bicyclic¬3.1.0|hexanes and related compounds |
| 03/17/2005 | WO2005023899A1 Acid-sensitive polyacetals and methods |
| 03/17/2005 | WO2005023756A1 Method for the manufacture of l-threonine-o-(1,1-dimethylethyl)-1,1-dimethylethyl ester |
| 03/17/2005 | WO2005023755A1 Novel method for synthesizing esters of n-[(s)-1-carboxybutyl]-(s)-alanine and use thereof for synthesizing perindopril |
| 03/17/2005 | WO2005000228A3 Synthesis of labeled oxalic acid derivatives |
| 03/17/2005 | WO2004096120A3 Compounds that selectively bind to membranes of apoptotic cells |
| 03/17/2005 | US20050059810 Dibenzylamine compound and medicinal use thereof |
| 03/17/2005 | US20050059737 Such as 3-pentenoic acid or fatty acid glycerides, using as catalyst a group 8 metal compound with a bis-phosphite ligand to form cyanoalkylcarboxylic acids or glycerides thereof; preparing their corresponding amines |
| 03/17/2005 | US20050059669 M-substituted benzoic acid derivatives having integrin alpha v beta 3 antagonistic activity |
| 03/17/2005 | CA2538175A1 Method for the manufacture of l-threonine-o-(1,1-dimethylethyl)-1,1-dimethylethyl ester |
| 03/16/2005 | EP1514541A1 Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders |
| 03/16/2005 | EP1513803A1 Ligands that are inhibitors of the rar receptors |
| 03/16/2005 | EP1513797A1 Agents and methods for the treatment of disorders associated with oxidative stress |
| 03/16/2005 | EP1349828B1 Process for preparing isomers of salbutamol |
| 03/16/2005 | EP1341799B1 P-chirale bisphospholane ligands, their transition metal complexes |
| 03/16/2005 | CN1596249A Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them |
| 03/16/2005 | CN1594282A Method for producing L-ornithine hydrochloride |
| 03/16/2005 | CN1594281A Process for preparing iminodiacetic acid |
| 03/16/2005 | CN1193003C Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 03/16/2005 | CN1193002C Compounds with particular structure and anticancer activity and its preparing process |
| 03/15/2005 | US6867327 Ultrapure 1,2diaminocycloalkyl-N,N,N1,N1-tetraacetic acid (CDTA) compounds and their use as stabilizers for hydroxylamine compounds used extensively in the production of high premium electronic components. |
| 03/15/2005 | US6867320 Prostaglandin inhibitor; suppression leukotriene; antiinflammatory agents; rheumatic diseases |
| 03/15/2005 | US6867310 Synthesize efficiently and under mild conditions alpha -aryl and alpha -vinyl products from a wide range of starting materials, including ketones, esters, hydrazones, and imines, enantiomorphs |
| 03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
| 03/15/2005 | US6867284 Fluorinated oligopeptides especially those having 4,4-difluoro- 2-amino butyric acid at the C terminus |
| 03/10/2005 | WO2005021485A2 Cycloalkylaminoacid compounds, processes for making and uses thereof |
| 03/10/2005 | WO2005020882A2 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 03/10/2005 | WO2004085661A3 Process to chiral beta-amino acid derivatives |
| 03/10/2005 | US20050054727 For treating or delaying progression or onset of obesity, hypercholesterolemia, atherosclerosis, depression, osteoporosis, hypothyroidism, non-toxic goiter, reduced bone mass, density or growth, eating disorders, cardiac arrhythmia |
| 03/10/2005 | CA2824106A1 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 03/10/2005 | CA2537093A1 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 03/10/2005 | CA2536901A1 Cycloalkylaminoacid compounds, processes for making and uses thereof |
| 03/09/2005 | EP1511736A1 Therapeutic molecules and methods-1 |